Poor information hampers discussion of HIV “super strain”BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7490.498 (Published 03 March 2005) Cite this as: BMJ 2005;330:498
- Bob Roehr
Controversy over a possible “super strain” of HIV has been burgeoning in the United States since the case of a man with a multidrug resistant virus with rare characteristics and very rapid disease progression was discussed at a high profile news conference in New York city last month. A report, by Marc Santora et al, was published in the New York Times (2005 Feb 12; www.nytimes.com/).
The first scientific presentation of the case came in a poster at the 12th retroviral conference in Boston. The organisers added a special session on drug resistance and rapid disease progression on the last evening of the conference to provide context for interpreting data from the poster.
Dr David Ho, director of the Aaron Diamond AIDS Research Center at Rockefeller University, New York, described the patient …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial